By Conjoint Professor David goldstein

Journal articles

Robinson SP; Goldstein D; Witt PL; Borden EC; Jordan VC, 1990, 'Inhibition of hormone-dependent and independent breast cancer cell growth in vivo and in vitro with the antiestrogen toremifene and recombinant human interferon-α2', Breast Cancer Research and Treatment, 15, pp. 95 - 101, http://dx.doi.org/10.1007/BF01810781

Goldstein D; Cheuvart B; Trump DL; Shiraki M; Comis RL; Tormey DC; Harris JE; Borden EC, 1990, 'Phase II trial of carboplatin in soft-tissue sarcoma', American Journal of Clinical Oncology Cancer Clinical Trials, 13, pp. 420 - 423, http://dx.doi.org/10.1097/00000421-199010000-00011

Laszlo J; Goldstein D; Gockerman J; Hood L; Huang AT; Triozzi P; Sedwick WD; Koren H; Ellinwood EH; Tso CY, 1990, 'Phase I studies of recombinant interferon-gamma.', J Biol Response Mod, 9, pp. 185 - 193, https://www.ncbi.nlm.nih.gov/pubmed/2160521

GOLDSTEIN D; SOSMAN JA; HANK JA; WEILHILLMAN G; MOORE KH; BORCHERT A; BECHHOFER R; STORER B; KOHLER PC; LEVITT D; SONDEL PM, 1989, 'REPETITIVE WEEKLY CYCLES OF INTERLEUKIN-2 - EFFECT OF OUTPATIENT TREATMENT WITH A LOWER DOSE OF INTERLEUKIN-2 ON NON-MAJOR HISTOCOMPATIBILITY COMPLEX-RESTRICTED KILLER ACTIVITY', CANCER RESEARCH, 49, pp. 6832 - 6839

Goldstein D; Sielaff KM; Stores BE; Brown RR; Datta SP; Witt PL; Teitelbaum AP; Smalley RV; Borden EC, 1989, 'Human biologic response modification by interferon in the absence of measurable serum concentrations: A comparative trial of subcutaneous and intravenous interferon-β serine', Journal of the National Cancer Institute, 81, pp. 1061 - 1068, http://dx.doi.org/10.1093/jnci/81.14.1061

Guadagni F; Schlom J; Johnston WW; Szpak CA; Goldstein D; Smalley R; Simpson JF; Borden EC; Pestka S; Greiner JW, 1989, 'Selective interferon-induced enhancement of tumor-associated antigens on a spectrum of freshly isolated human adenocarcinoma cells', Journal of the National Cancer Institute, 81, pp. 502 - 512, http://dx.doi.org/10.1093/jnci/81.7.502

Goldstein D; Bushmeyer SM; Witt PL; Jordan VC; Borden EC, 1989, 'Effects of Type I and II Interferons on Cultured Human Breast Cells: Interaction with Estrogen Receptors and with Tamoxifen', Cancer Research, 49, pp. 2698 - 2702

Goldstein D; Levi JA; Woods RL; Russell J; Morgan J; Kerestes Z, 1989, 'Double-blind randomized cross-over trial of dexamethasone and prochlorperazine as anti-emetics for cancer chemotherapy', Oncology Switzerland, 46, pp. 105 - 108, http://dx.doi.org/10.1159/000226695

Laszlo J; Goldstein D, 1988, 'The doctor's dilemma (the nurse's Waterloo)', Cancer Investigation, 6, pp. 361 - 363, http://dx.doi.org/10.3109/07357908809080660

Goldstein D; Laszlo J, 1988, 'The role of interferon in cancer therapy: A current perspective', CA A Cancer Journal for Clinicians, 38, pp. 258 - 277, http://dx.doi.org/10.3322/canjclin.38.5.258

Triozzi PL; Goldstein D; Laszlo J, 1988, 'Contributions of benzodiazepines to cancer therapy.', Cancer Invest, 6, pp. 103 - 111, http://dx.doi.org/10.3109/07357908809077033

Goldstein D; Kelly R; Ralston M; Penny R; Hayes J, 1987, 'Chemotherapy influencing the course of nephrotic syndrome in colonic carcinoma', Medical Oncology and Tumor Pharmacotherapy, 4, pp. 101 - 105, http://dx.doi.org/10.1007/BF02934947

Goldstein D; Gockerman J; Tso CY; Hood LE, 1987, 'Effects of 7-Interferon on the Endocrine System: Results from a Phase I Study', Cancer Research, 47, pp. 6397 - 6401

Goldstein D; Laszlo J, 1986, 'Interferon Therapy in Cancer: From Imaginon to Interferon', Cancer Research, 46, pp. 4315 - 4329

Geczy CL; Ryan J; Walsh J; Goldstein D, 1986, 'Lymphokine‐induced monocyte procoagulant activity is depressed in patients with advanced malignancies', International Journal of Cancer, 37, pp. 677 - 682, http://dx.doi.org/10.1002/ijc.2910370506

Laszlo J; Goldstein D; Vugrin D; Hood L; Tso CY, 1986, 'Does maintenance therapy with alpha interferon stabilize cancer growth? A pilot study.', J Biol Response Mod, 5, pp. 294 - 299, https://www.ncbi.nlm.nih.gov/pubmed/3734845

Back to profile page